Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Understanding how microglia change their states to adapt to different areas of the brain

In this interview, News Medical speaks to Jeffrey Stogsdill, Ph.D., about his latest research exploring how microglia change their state to adapt to different areas of the brain.

2 Sep 2022

Gene variants associated with blood type may contribute to risk of early stroke

Gene variants associated with a person's blood type may be linked to their risk of early stroke, according to a new meta-analysis published in the August 31, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Sep 2022

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

Researchers map the proteomes of peripheral blood neutrophils isolated from hospitalized COVID-19 patients using high-resolution LC-MS.

25 Aug 2022

COVID-19 vaccine not linked to increased risk of stroke

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does.

24 Aug 2022

Study investigates associations between MS prevalence and factors driving regional differences

Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure.

24 Aug 2022

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

In a newly released study, researchers explored the sotrovimab uptake for severe COVID-19 prophylaxis and its safety across the community populations in England.

22 Aug 2022

MS Australia announces new round of incubator grants for innovative research on multiple sclerosis

MS Australia has announced its new round of incubator grants for 'out-of-the-box' Australian research projects that will explore innovative ways to prevent and treat multiple sclerosis (MS), including new research that will further explore the prevalence and incidence of MS in different parts of Australia.

22 Aug 2022

Women with epilepsy have more depression and anxiety symptoms during pregnancy and postpartum

Pregnant women with epilepsy have more symptoms of depression and anxiety during pregnancy and postpartum than pregnant women who do not have epilepsy or women with epilepsy who are not pregnant, according to a study published in the August 17, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Aug 2022

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways that lead to drug resistance while increasing cancer-fighting ability and reducing side effects.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting against glaucoma.

16 Aug 2022

Interferon beta reduces binding of three components to RBCs, study finds

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce proinflammatory molecules and even increase production of anti-inflammatory species in MS patients.

11 Aug 2022

Specific factors may affect physical and mental quality of life among people with multiple sclerosis

Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a person's physical and mental quality of life.

10 Aug 2022

Leisure activities may help lower the risk of dementia

Leisure activities, such as reading a book, doing yoga and spending time with family and friends, may help lower the risk of dementia, according to a new meta-analysis published in the August 10, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Aug 2022

Study uncovers new prognostic marker for multiple sclerosis severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods.

10 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

National MS Society commits $19 million to launch 40 multi-year research awards to drive progress towards new cures

The National Multiple Sclerosis Society has committed $19 million to launch 40 new multi-year research awards to drive progress toward stopping MS, restoring function, and ending MS forever – the goals of the widely endorsed Pathways to Cures for MS to better align the global MS research community around the most promising areas to cure MS for every single person as fast as possible.

4 Aug 2022

Research describes how the thymus teaches T cells to recognize friendly proteins

T cells are a special class of white blood cells that patrol the body and attack infected or foreign tissue. They learn to distinguish friendly proteins from dangerous ones in an organ called the thymus.

2 Aug 2022

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.

1 Aug 2022

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Understanding how microglia change their states to adapt to different areas of the brain

Gene variants associated with blood type may contribute to risk of early stroke

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

COVID-19 vaccine not linked to increased risk of stroke

Study investigates associations between MS prevalence and factors driving regional differences

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

MS Australia announces new round of incubator grants for innovative research on multiple sclerosis

Women with epilepsy have more depression and anxiety symptoms during pregnancy and postpartum

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Interferon beta reduces binding of three components to RBCs, study finds

Specific factors may affect physical and mental quality of life among people with multiple sclerosis

Leisure activities may help lower the risk of dementia

Study uncovers new prognostic marker for multiple sclerosis severity

Fatigue and headache among the most common symptoms following COVID-19 infections

National MS Society commits $19 million to launch 40 multi-year research awards to drive progress towards new cures

Research describes how the thymus teaches T cells to recognize friendly proteins

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in